Adaptive Biotechnologies (ADPT) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Adaptive Biotechnologies

· ADPT

Dashboard

Financials

KPIs

Ratios

Transcripts

Valuation

Statistics

4.592 B

+0.45%

Adaptive Biotechnologies (ADPT) Company Statistics | The Fly

General

Market Cap: $4.59B
Enterprise Value: $4.87B
Shares Outstanding: 159,060,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 75.44%
Operating Margin: -12.16%
Net Profit Margin: -20.73%
FCF Margin: -7.80%
ROA: -9.97%
ROE: -32.64%
ROIC: -6.67%
Current Ratio: 4.79
Debt-to-Equity: 2.87
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 15.01
P/FCF: —
P/B: 30.70
EV/EBITDA: -304.84

Growth

Rev 1Y: 54.77%
Rev 1Y Fwd Est: 5.96%
Rev 3Y (CAGR): 14.34%
Rev 5Y (CAGR): 23.00%
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —

Income Statement (TTM)

Revenue: $308.08M
Gross Margin: 75.44%
Operating Expenses: $269.86M
Operating Income: -$37.46M
Net Profit: -$63.85M

Balance Sheet

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $169.87M
Working Capital: $332.85M
Total Assets: $640.68M
Net Debt: $240.63M
Total Liabilities: $490.02M
Total Equity: $150.66M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$21.01M
Cash Flow from Investing: -$25.3M
Cash Flow from Financing: $173.03M
Free Cash Flow: -$24.03M
Capital Expenditures: $3.03M